QbD product development: rapid optimization and scale-up of PBAE-based siRNA delivery via DoE-guided microfluidics.

Kromer APE, Eller LJM, Jürgens DC, Merkel OM

DOI: 10.1039/d5pm00379b
Published: 2026 Mar 24
Container: RSC pharmaceutics
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1039/d5pm00379b,
  title = {QbD product development: rapid optimization and scale-up of PBAE-based siRNA delivery via DoE-guided microfluidics.},
  author = {Kromer APE and Eller LJM and Jürgens DC and Merkel OM},
  year = {2026},
  journal = {RSC pharmaceutics},
  doi = {10.1039/d5pm00379b},
  url = {https://doi.org/10.1039/d5pm00379b}
}

RIS

TY  - JOUR
TI  - QbD product development: rapid optimization and scale-up of PBAE-based siRNA delivery via DoE-guided microfluidics.
AU  - Kromer APE
AU  - Eller LJM
AU  - Jürgens DC
AU  - Merkel OM
PY  - 2026
JO  - RSC pharmaceutics
DO  - 10.1039/d5pm00379b
UR  - https://doi.org/10.1039/d5pm00379b
ER  -

APA

APE, K., LJM, E., DC, J., & OM, M. (2026). QbD product development: rapid optimization and scale-up of PBAE-based siRNA delivery via DoE-guided microfluidics.. RSC pharmaceutics. https://doi.org/10.1039/d5pm00379b

Source records

pubmed · retrieved 2026-11-10T10:49:07.993Z